The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

Introduction: Cetuximab and panitumumab has been used clinically to treat metastatic colorectal cancer for over 15 years. Before the treatment is given, it is necessary to determine the KRAS mutation status because it would lead to drug resistance. tumor tissue sample is traditionally used for genotyping of cancer. In recent years, the biopsy sample liquid has been intensively investigated as a substitute for tumor tissue samples for non-invasive and better presentation of tumor heterogeneity.

The purpose of this study was to systematically summarize the accuracy of the measurement of KRAS mutations in colorectal cancer using the cell-free DNA in the sample liquid biopsy, the tumor tissue samples as reference (gold standard).
Methods and analysis: We will find literature in the following databases: Pubmed, Embase, and the Cochrane Library. systemic review and meta-analysis will be conducted to summarize the accuracy of the measurement of KRAS mutations in colorectal cancer using biopsy samples of liquid and subgroup analyzes will be performed on different testing platforms, and in colorectal cancer metastatic and non-metastatic.
Timeline: The research will begin on June 1, 2020, and is expected to be completed date of 1 November 2020.


Ethics and deployment: Ethics approval will not be required because the data obtained and analyzed in this study will not be in each patient. The results of the research will be disseminated as an official publication in peer-reviewed

A PCR-based NGS protocol for whole genome sequencing of West Nile virus 2 direct descendant of biological specimens.

Lineage 2 West Nile virus (WNV) strain has been involved in a severe outbreak of encephalitis in humans and equines which are in Europe. WNV molecular characterization is important for the development of diagnostic tests, and to obtain molecular information, which is necessary for epidemiological investigations in areas at risk of virus transmission.

For whole-genome sequencing of strains of WNV lineage 2, directly from biological specimens, PCR-based NGS protocol developed. This method is applied to the WNV-positive specimens were obtained from animals, human and mosquito hosts in Greece. Outcomes of the application shows that, even in the case of a low viral titers, developed PCR-based NGS approach capable of providing whole genome sequence of strain lineage 2 WNV.

The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis
The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

The latest trends in molecular diagnostics yeast infection: PCR for NGS.

The incidence of opportunistic yeast infections in humans has increased in recent years. These infections are difficult to treat and diagnose, partly because the large number and wide variety of species that can be underlying infection.

Moreover, resistance to one or more of antifungal drugs in a strain that infects more and more reported, severely limiting therapeutic options and to show the need for rapid detection of infecting agents and the profile of its drug susceptibility.

Current methods for species identification of constraints and shortage of sensitivity and specificity were satisfactory, and often require a previous culture of the infecting agent, which delays diagnosis.

Recently developed high-throughput technologies such as next-generation sequencing or proteomics opens a completely new way to diagnose more sensitive, accurate and rapid pathogenic yeast. These approaches are the focus of intensive research, but the translation to the clinic needed to overcome important challenges. In this review, we provide an overview of existing approaches and recently appeared which can be used in the identification of the yeast pathogens and their drug resistance profile.

Cd79b (untagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), (10 ug)

RN207564 10 µg Ask for price

CD79B, Sf9

pro-2404 2µg
EUR 60
Description: Recombinant Human CD79B, Sf9

CD79B siRNA

20-abx911073
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

CD79B siRNA

20-abx911074
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

CD79B Protein

20-abx260988
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

CD79B Protein

abx260988-10g 10 µg
EUR 325

CD79B Protein

abx260988-2g 2 µg
EUR 225

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

SC304941 10 µg Ask for price

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

SC321002 10 µg Ask for price

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1

SC122570 10 µg Ask for price

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

SC311082 10 µg Ask for price

CD79b antibody

10R-CD79baHU 100 ug
EUR 179
Description: Mouse monoclonal CD79b antibody

CD79b antibody

10R-CD79bbMS 500 ug
EUR 385
Description: Hamster monoclonal CD79b antibody

CD79B Antibody

32563 100ul
EUR 439

CD79B Antibody

32563-100ul 100ul
EUR 302.4

CD79B Antibody

E10-31452 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Antibody

E11-184649 100ug/100ul
EUR 225
Description: Available in various conjugation types.

CD79B Antibody

DF6767 200ul
EUR 420

CD79B Antibody

E92033 100ul
EUR 255
Description: Available in various conjugation types.

CD79b Antibody

E38PA3830 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Antibody

AF4649 200ul
EUR 540

CD79B Antibody

AF4649-100ul 100ul
EUR 350

CD79B Antibody

AF4649-200ul 200ul
EUR 450

CD79B Antibody

AF4649-50ul 50ul
EUR 250

CD79B Antibody

CSB-PA004958KA01HU- each
EUR 402
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CD79B Antibody

CSB-PA004958KA01HU-100ul 100ul
EUR 466.8
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CD79B Antibody

1-CSB-PA004958LA01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200

CD79B Antibody

1-CSB-PA005233
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

CD79B Antibody

ABD6767 100ug
EUR 325

CD79b Antibody

F44972-0.08ML 0.08 ml
EUR 140.25
Description: The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.

CD79b Antibody

F44972-0.4ML 0.4 ml
EUR 322.15
Description: The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.

CD79b Antibody

GWB-49F5BF 0.1 mg Ask for price

CD79b Antibody

GWB-7F7827 0.2 mg Ask for price

CD79b Antibody

GWB-BCA369 0.02 mg Ask for price

CD79b Antibody

R31586 100 ug
EUR 356.15
Description: Cluster of Differentiation 79b, is a human gene mapped to 17q23.3. The CD79b protein together with the relatedCD79aprotein, forms a dimer associated with membrane bound immunoglobulin in B-cells, thus forming the B-cell antigen receptor (BCR) which is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). CD79b also enhances phosphorylation of CD79a, possibly by recruiting kinases, or by recruiting proteins which bind to CD79a and protect it from dephosphorylation.

CD79b Antibody

RQ5654 100 ug
EUR 356.15
Description: CD79b molecule, immunoglobulin-associated beta, also known as CD79B (Cluster of Differentiation 79B), is a human gene. By fluorescence in situ hybridization, It is mapped to 17q23.3. The CD79B protein together with the related CD79A protein, forms a dimer associated with membrane bound immunoglobulin in B-cells, thus forming the B-cell antigen receptor (BCR) which is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). CD79b also can enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation.

CD79b Antibody

V8930-100UG 100ug
EUR 349.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8930-20UG 20ug
EUR 153.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8930SAF-100UG 100ug
EUR 349.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128-100UG 100ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128-20UG 20ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128SAF-100UG 100ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3810-100UG 100 ug
EUR 424.15
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3810-20UG 20 ug
EUR 186.15
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3810SAF-100UG 100 ug
EUR 424.15
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3956-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3956-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3956SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79B Antibody

MBS7044481-005mg 0.05mg
EUR 190

CD79B Antibody

MBS7044481-01mg 0.1mg
EUR 270

CD79B Antibody

MBS7044481-5x01mg 5x0.1mg
EUR 1205

CD79B Antibody

MBS7117491-005mg 0.05mg
EUR 150

CD79B Antibody

MBS7117491-01mg 0.1mg
EUR 190

CD79B Antibody

MBS7117491-5x01mg 5x0.1mg
EUR 845

CD79B Antibody

MBS9402310-005mL 0.05mL
EUR 300

CD79B Antibody

MBS9402310-01mL 0.1mL
EUR 390

CD79B Antibody

MBS9402310-5x01mL 5x0.1mL
EUR 1610

CD79b Antibody

MBS8582181-01mL 0.1mL
EUR 305

CD79b Antibody

MBS8582181-01mLAF405L 0.1mL(AF405L)
EUR 465

CD79b Antibody

MBS8582181-01mLAF405S 0.1mL(AF405S)
EUR 465

CD79b Antibody

MBS8582181-01mLAF610 0.1mL(AF610)
EUR 465

CD79b Antibody

MBS8582181-01mLAF635 0.1mL(AF635)
EUR 465

CD79B Antibody

MBS8501144-01mL 0.1mL
EUR 325

CD79B Antibody

MBS8501144-01mLAF610 0.1mL(AF610)
EUR 565

CD79B Antibody

MBS8501144-01mLAF405L 0.1mL(AF405L)
EUR 565

CD79B Antibody

MBS8501144-01mLAF405S 0.1mL(AF405S)
EUR 565

CD79B Antibody

MBS8501144-01mLAF635 0.1mL(AF635)
EUR 565

CD79B Antibody

MBS8529189-01mg 0.1mg
EUR 305

CD79B Antibody

MBS8529189-01mLAF405L 0.1mL(AF405L)
EUR 465

CD79B Antibody

MBS8529189-01mLAF405S 0.1mL(AF405S)
EUR 465

CD79B Antibody

MBS8529189-01mLAF610 0.1mL(AF610)
EUR 465

CD79B Antibody

MBS8529189-01mLAF635 0.1mL(AF635)
EUR 465

CD79B Antibody

MBS2524489-006mL 0.06mL
EUR 230

CD79B Antibody

MBS2524489-012mL 0.12mL
EUR 310

CD79B Antibody

MBS2524489-02mL 0.2mL
EUR 480

CD79b antibody

MBS531996-05mg 0.5mg
EUR 695

CD79b antibody

MBS531996-5x05mg 5x0.5mg
EUR 2965

CD79b antibody

MBS531128-INQUIRE INQUIRE Ask for price

CD79B Antibody

MBS9613357-005mL 0.05mL
EUR 245

CD79B Antibody

MBS9613357-01mL 0.1mL
EUR 305

CD79B Antibody

MBS9613357-02mL 0.2mL
EUR 365

CD79B Antibody

MBS9613357-5x02mL 5x0.2mL
EUR 1495

CD79B Antibody

MBS9607423-01mL 0.1mL
EUR 260

CD79B Antibody

MBS9607423-02mL 0.2mL
EUR 305

CD79B Antibody

MBS9607423-5x02mL 5x0.2mL
EUR 1220

CD79B Antibody

MBS9507538-005mL 0.05mL
EUR 285

CD79B Antibody

MBS9507538-01mL 0.1mL
EUR 385

CD79B Antibody

MBS9507538-5x01mL 5x0.1mL
EUR 1590

CD79b Antibody

C30384-100ul 100μl
EUR 217
Description: CD79b Rabbit Polyclonal Antibody

CD79b Antibody

C30384-50ul 50μl
EUR 143.5
Description: CD79b Rabbit Polyclonal Antibody

CD79B Antibody

DF6767-100ul 100ul
EUR 168
Description: WB,IHC,ELISA(peptide)

CD79B Antibody

DF6767-200ul 200ul
EUR 210
Description: WB,IHC,ELISA(peptide)

CD79b Antibody

V4533-100UG 100ug
EUR 363.3
Description: CD79 (also designated Ig Alpha/Ig beta) is a heterodimer composed of Alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V4533-20UG 20ug
EUR 160.3
Description: CD79 (also designated Ig Alpha/Ig beta) is a heterodimer composed of Alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V4533SAF-100UG 100ug
EUR 363.3
Description: CD79 (also designated Ig Alpha/Ig beta) is a heterodimer composed of Alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79B (GFP-tagged) - Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

RG217693 10 µg Ask for price

CD79B (GFP-tagged) - Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

RG200665 10 µg Ask for price

CD79B (GFP-tagged) - Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1

RG215340 10 µg Ask for price

Lenti ORF particles, Cd79b (GFP-tagged) - Mouse CD79B antigen (Cd79b), 200ul, >10^7 TU/mL

MR202725L4V 200 µl Ask for price

Cd79b (Myc-DDK-tagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), (10 ug)

RR207564 10 µg Ask for price

Lenti ORF particles, Cd79b (Myc-DDK-tagged) - Mouse CD79B antigen (Cd79b), 200ul, >10^7 TU/mL

MR202725L3V 200 µl Ask for price

CD79B (Myc-DDK-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

RC200665 10 µg Ask for price

CD79B (Myc-DDK-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

RC217693 10 µg Ask for price

CD79B (Myc-DDK-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1

RC215340 10 µg Ask for price

CD79B Rabbit pAb

E2382394 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Rabbit pAb

E2382681 100ul
EUR 225
Description: Available in various conjugation types.

CD79b Rabbit pAb

E2251516 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Rabbit mAb

A4362 20 μL
EUR 778.7
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 1301-1580 of human Gli3 (P10071).

CD79B Rabbit mAb

56362 100ul
EUR 339

CD79b Rabbit mAb

56964 100ul
EUR 339

CD79B Rabbit pAb

A2033-100ul 100 ul
EUR 369.6

CD79B Rabbit pAb

A2033-200ul 200 ul
EUR 550.8

CD79B Rabbit pAb

A2033-20ul 20 ul
EUR 219.6

CD79B Rabbit pAb

A2033-50ul 50 ul
EUR 267.6

CD79B Rabbit mAb

A21224 500μL
EUR 213.2
Description: A synthetic peptide corresponding to a sequence within amino acids 630-647 of human LIM kinase 1(LIMK1)(NP_002305.1).

CD79B Rabbit mAb

A23790 100μL
EUR 213.2
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 2645-2813 of human von Willebrand factor (VWF) (NP_000543.3).

CD79B cDNA Clone

MBS1267202-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 200

CD79B cDNA Clone

MBS1267202-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 855

CD79B cDNA Clone

MBS1268758-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 200

CD79B cDNA Clone

MBS1268758-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 855

CD79b Rabbit mAb

E2R382394 100ul
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

CD79B Rabbit pAb

MBS8575848-01mL 0.1mL
EUR 305

CD79B Rabbit pAb

MBS8575848-01mLAF405L 0.1mL(AF405L)
EUR 565

CD79B Rabbit pAb

MBS8575848-01mLAF405S 0.1mL(AF405S)
EUR 565

CD79B Rabbit pAb

MBS8575848-01mLAF610 0.1mL(AF610)
EUR 565

CD79B Rabbit pAb

MBS8575848-01mLAF635 0.1mL(AF635)
EUR 565

CD79B Rabbit pAb

MBS8543846-01mL 0.1mL
EUR 305

CD79B Rabbit pAb

MBS8543846-01mLAF405L 0.1mL(AF405L)
EUR 565

CD79B Rabbit pAb

MBS8543846-01mLAF405S 0.1mL(AF405S)
EUR 565

CD79B Rabbit pAb

MBS8543846-01mLAF610 0.1mL(AF610)
EUR 565

CD79B Rabbit pAb

MBS8543846-01mLAF635 0.1mL(AF635)
EUR 565

CD79B Rabbit pAb

MBS8540127-01mL 0.1mL
EUR 305

CD79B Rabbit pAb

MBS8540127-01mLAF405L 0.1mL(AF405L)
EUR 565

CD79B Rabbit pAb

MBS8540127-01mLAF405S 0.1mL(AF405S)
EUR 565

CD79B Rabbit pAb

MBS8540127-01mLAF610 0.1mL(AF610)
EUR 565

CD79B Rabbit pAb

MBS8540127-01mLAF635 0.1mL(AF635)
EUR 565

CD79B Rabbit pAb

A2033 200μL
EUR 88.56

CD79B Rabbit mAb

A22382 200μL
EUR 1657.89

CD79B Rabbit mAb

A23459 1000μL
EUR 828.95

CD79b antibody (PE)

61R-1273 100 tests
EUR 489
Description: Mouse monoclonal CD79b antibody (PE)

CD79b antibody (PE)

61R-CD79bbMSPE 100 ug
EUR 299
Description: Hamster monoclonal CD79b antibody (PE)

CD79b Antibody (PE)

GWB-BCEFBD 100 TESTS Ask for price

CD79B siRNA (Human)

MBS8232367-15nmol 15nmol
EUR 405

CD79B siRNA (Human)

MBS8232367-30nmol 30nmol
EUR 565

CD79B siRNA (Human)

MBS8232367-5x30nmol 5x30nmol
EUR 2450

CD79B siRNA (Mouse)

MBS8237999-15nmol 15nmol
EUR 405

CD79B siRNA (Mouse)

MBS8237999-30nmol 30nmol
EUR 565

CD79B siRNA (Mouse)

MBS8237999-5x30nmol 5x30nmol
EUR 2450

CD79b antibody (PE)

MBS532656-01mg 0.1mg
EUR 565

CD79b antibody (PE)

MBS532656-5x01mg 5x0.1mg
EUR 2385

CD79B Antibody (HRP)

20-abx312629
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Throughout the text we highlight the advantages and disadvantages of each methodology and discuss the most promising developments in their path from bench to bedside.

Leave A Comment